These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 24560352

  • 1. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.
    Athawale RB, Jain DS, Singh KK, Gude RP.
    Biomed Pharmacother; 2014 Mar; 68(2):231-40. PubMed ID: 24560352
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X, Lee KC.
    Int J Pharm; 2011 Jan 17; 403(1-2):285-91. PubMed ID: 21035530
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel-loaded glyceryl palmitostearate nanoparticles: in vitro release and cytotoxic activity.
    Shenoy VS, Gude RP, Murthy RS.
    J Drug Target; 2009 May 17; 17(4):304-10. PubMed ID: 19255897
    [Abstract] [Full Text] [Related]

  • 5. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery.
    Wang Z, Li Z, Zhang D, Miao L, Huang G.
    Drug Deliv; 2015 Jan 17; 22(1):79-85. PubMed ID: 24401038
    [Abstract] [Full Text] [Related]

  • 6. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.
    Mundra V, Peng Y, Kumar V, Li W, Miller DD, Mahato RI.
    Drug Deliv Transl Res; 2015 Jun 17; 5(3):199-208. PubMed ID: 25924699
    [Abstract] [Full Text] [Related]

  • 7. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.
    Sahu PK, Mishra DK, Jain N, Rajoriya V, Jain AK.
    Drug Dev Ind Pharm; 2015 Apr 17; 41(4):640-9. PubMed ID: 24564799
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
    Fatma S, Talegaonkar S, Iqbal Z, Panda AK, Negi LM, Goswami DG, Tariq M.
    Drug Deliv; 2016 Apr 17; 23(2):500-11. PubMed ID: 24937381
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Experimental design towards an optimal lipid nanosystem: a new opportunity for paclitaxel-based therapeutics.
    Videira MA, Arranja AG, Gouveia LF.
    Eur J Pharm Sci; 2013 May 13; 49(2):302-10. PubMed ID: 23528739
    [Abstract] [Full Text] [Related]

  • 12. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
    Guo X, Xing Y, Mei Q, Zhang H, Zhang Z, Cui F.
    Anticancer Drugs; 2012 Feb 13; 23(2):185-90. PubMed ID: 22027535
    [Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
    Kılıçay E, Demirbilek M, Türk M, Güven E, Hazer B, Denkbas EB.
    Eur J Pharm Sci; 2011 Oct 09; 44(3):310-20. PubMed ID: 21884788
    [Abstract] [Full Text] [Related]

  • 14. Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies.
    Dodiya S, Chavhan S, Korde A, Sawant KK.
    Drug Dev Ind Pharm; 2013 May 09; 39(5):733-43. PubMed ID: 22690834
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
    Martins SM, Sarmento B, Nunes C, Lúcio M, Reis S, Ferreira DC.
    Eur J Pharm Biopharm; 2013 Nov 09; 85(3 Pt A):488-502. PubMed ID: 23994244
    [Abstract] [Full Text] [Related]

  • 17. Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studies.
    Gao F, Li L, Zhang H, Yang W, Chen H, Zhou J, Zhou Z, Wang Y, Cai Y, Li X, Liu L, Zhang Q.
    Int J Pharm; 2010 Jun 15; 392(1-2):254-60. PubMed ID: 20347028
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
    Aji Alex MR, Chacko AJ, Jose S, Souto EB.
    Eur J Pharm Sci; 2011 Jan 18; 42(1-2):11-8. PubMed ID: 20971188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.